Ameritas Advisory Services’s Edwards Lifesciences EW Stock Holding History

Ameritas Advisory Services’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-126	Closed	-$9.8K	–	1287
2025 Q3	$9.8K	Sell	126 -1,002	-89%	-$78.3K	﹤0.01%	1664
2025 Q2	$88.2K	Buy	+1,128	New	+$84.1K	﹤0.01%	1042
2024 Q2	–	Sell	-3,269	Closed	-$311K	–	904
2024 Q1	$311K	Buy	+3,269	New	+$275K	0.01%	699
2023 Q2	–	Sell	-2,765	Closed	-$237K	–	1155
2023 Q1	$237K	Sell	2,765 -1,998	-42%	-$157K	0.01%	716
2022 Q4	$355K	Buy	4,763 +1,948	+69%	+$150K	0.02%	652
2022 Q3	$233K	Buy	2,815 +39	+1%	+$3.75K	0.01%	669
2022 Q2	$264K	Sell	2,776 -30	-1%	-$3.11K	0.02%	659
2022 Q1	$330K	Sell	2,806 -247	-8%	-$27.7K	0.01%	632
2021 Q4	$395K	Buy	+3,053	New	+$356K	0.01%	566

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameritas Advisory Services's EW Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 126 shares — an estimated $9.8K sold.

Ameritas Advisory Services first reported a position in EW in Q4 2021 and held it in 9 quarters. The position peaked at $395K in Q4 2021. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Ameritas Advisory Services reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Ameritas Advisory Services sold 126 Edwards Lifesciences shares in Q4 2025, an estimated $9.8K.
Ameritas Advisory Services first reported a position in Edwards Lifesciences in Q4 2021 and held it in 9 quarters.
Ameritas Advisory Services's Edwards Lifesciences position peaked at $395K in Q4 2021.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.